The role of mannose-binding lectin in susceptibility to infection in preterm neonates

Pediatric Research

Volumn 63, Issue 6, 2008, Pages 680-685

  Dzwonek, Agnieszka B ^a,b   Neth, Olaf W ^a   ThiIbaut, Rodolphe ^a,d   Gulczynska, Ewa ^b   Chilton, Marcia ^c   Hellwig, Thomas ^c   Bajaj Elliott, Mona ^a   Hawdon, Jane ^c   Klein, Nigel J ^a,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d INSERM   (France)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MANNOSE BINDING LECTIN; ANTIINFECTIVE AGENT; MBL2 PROTEIN, HUMAN;

ARTICLE; BACTEREMIA; CANDIDA ALBICANS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENE MUTATION; GENOTYPE; GESTATIONAL AGE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEWBORN; NEWBORN INFECTION; NEWBORN SEPSIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RANDOMIZED CONTROLLED TRIAL; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTREMELY LOW BIRTH WEIGHT; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; METABOLISM; MICROBIOLOGY; PHENOTYPE; POLAND; PROSPECTIVE STUDY; RISK FACTOR; SEPSIS; TIME; UNITED KINGDOM; VERY LOW BIRTH WEIGHT;

ANTI-BACTERIAL AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; LONDON; MANNOSE-BINDING LECTIN; PHENOTYPE; POLAND; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 45849085813     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31816fdbff     Document Type: Article

References (40)

1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK 2002 Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110:285-291
2. Palazzi DL, Klein JO, Baker CJ 2005 Bacterial sepsis and meningitis. In: Remington J, Klein J, Baker C, Wilson C (eds) Infectious Diseases of the fetus and newborn infant, 6th edition. Elsevier Saunders, Philadelphia, pp 247-296
3. Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, Laptook A, Walsh M, Oh W, Hall E 2005 Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network 2002-2003. Pediatr Infect Dis J 24:635-639
4. Sandberg K, Fasth A, Berger A 2000 Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr 137:623- 628
5. Luck S, Torny M, d'Agapeyeff K 2003 Estimated early-onset group B streptococcal neonatal disease. Lancet 361:1953-1954
6. Christensen KK, Christensen P, Duc G 1984 Correlation between serum antibody-levels against group B streptococci and gestational age in newborns. Eur J Pediatr 142:86-88
7. Lin FY, Philips JB, Azimi PH 2001 Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. J Infect Dis 184:1022-1028
8. Geelen SP, Fleer A, Bezemer AC 1990 Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies. Pediatr Res 27:514 -518
9. Schibler KR, Liechty KW, White WL, Christensen RD 1993 Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates. Blood 82:2478 -2484
10. Turner MW 2003 The role of mannose-binding lectin in health and disease. Mol Immunol 40:423-429
11. Jack DL, Turner MW 2003 Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 31:753-757
12. Gadjeva M, Takahashi K, Thiel S 2004 Mannan-binding lectin - a soluble pattern recognition molecule. Mol Immunol 41:113-121
13. Ezekowitz RA, Shi L, Fraser I, Takahashi K 2005 The mannose-binding lectin: an infection susceptibility gene. Adv Exp Med Biol 560:99 -103
14. Neth O, Jack DL, Dodds AW, Holzel H 2000 Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 68:688-693
15. Tenner AJ, Robinson SL, Ezekowitz RA 1995 Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M (r) component of the C1q receptor. Immunity 3:485-493
16. Jack DL, Klein NJ, Turner MW 2001 Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 180:86-99
17. Petersen SV, Thiel S, Jensenius JC 2001 The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 38:133-149
18. Turner MW, Lipscombe RJ, Levinsky RJ 1993 Mutations in the human mannose binding protein gene: their frequencies in three distinct populations and relationship to serum levels of the protein. Immunodeficiency 4:285-287
19. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW 1995 Distinct physico-chemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 85:660-667
20. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, Svejgaard A 1995 Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155:3013-3020
21. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P 1998 Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 161:3169-3175
22. Summerfield JA, Sumiya M, Levin M, Turner MW 1997 Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 314:1229-1232
23. Koch A, Melbye M, Sorensen P 2001 Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 285:1316 -1321
24. Neth O, Hann I, Turner MW, Klein NJ 2001 Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 358:614-618
25. Eisen DP, Minchinton RM 2003 Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 37:1496 -1505
26. Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ 2004 Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med 30:1438-1445
27. Terai I, Kobayashi K 1993 Perinatal changes in serum mannose-binding protein (MBP) levels. Immunol Lett 38:185-187
28. Thiel S, Bjerke T, Hansen D, Poulsen LK, Schiotz PO, Jensenius JC 1995 Ontogeny of human mannan-binding protein, a lectin of the innate immune system. Pediatr Allergy Immunol 6:20-23
29. Lau YL, Chan SY, Turner MW 1995 Mannose-binding protein in preterm infants: developmental profile and clinical significance. Clin Exp Immunol 102:649-654
30. Hilgendorff A, Schmidt R, Bohnert A 2005 Host defence lectins in preterm neonates. Acta Paediatr 94:794 -799
31. Frakking FN, Brouwer N, Zweers D, Merkus MP, Kuijpers TW, Offringa M, Dolman KM 2006 High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates. Clin Exp Immunol 145:5-12
32. Jack D, Bidwell J, Turner M, Wood N 1997 Simultaneous genotyping for all three known structural mutations in the human mannose-binding lectin gene. Hum Mutat 9:41-46
33. Turner MW, Dinan L, Heatley S, Jack DL, Boettcher B, Lester S, McCluskey J, Roberton D 2000 Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians. Hum Mol Genet 9:1481-1486
34. Dzwonek A, Novelli V, Bajaj-Elliott M, Turner M, Clapson M, Klein N 2006 Mannose-binding lectin in susceptibility and progression of HIV-1 infection in children. Antivir Ther 11:449 -505
35. Laird NM, Ware JH 1982 Random-effects models for longitudinal data. Biometrics 38:963-974
36. De Benedetti F, Auriti C, D'Urbano LE, Ronchetti MP, Rava L, Tozzi A, Ugazio AG, Orzalesi MM 2007 Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis. Pediatr Res 61:325-328
37. Neth O, Jack DL, Johnson M, Klein NJ, Turner MW 2002 Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J Immunol 169:4430-4436
38. Shi L, Takahashi K, Dundee J, Shahroor-Karni S, Thiel S, Jensenius JC, Gad F, Hamblin MR, Sastry KN, Ezekowitz RA 2004 Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 199:1379 -1390
39. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ 2001 Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 184:1152-1162
40. Valdimarsson H, Vikingsdottir T, Bang P, Saevarsdottir S, Gudjonsson JE, Oskars-son O, Christiansen M, Blou L, Laursen I, Koch C 2004 Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 59:97-102